Cutting edge: A-kinase anchor proteins are involved in maintaining resting T cells in an inactive state

Richard O Williams1

  • 1Kennedy Institute of Rheumatology Division, Imperial College of Science, Technology, and Medicine, London, United Kingdom. richard.o.williams@ic.ac.uk

Insights

A-kinase anchor proteins (AKAPs) regulate T cell signaling by anchoring protein kinase A (PKA). Disrupting this interaction boosts cytokine production and T cell proliferation, impacting cAMP signal sensitivity.

Area of Science:

  • Immunology
  • Cellular Signaling
  • Molecular Biology

Background:

  • A-kinase anchor proteins (AKAPs) localize protein kinase A (PKA) within cells.
  • AKAPs are crucial for cAMP signaling pathways.
  • The role of AKAPs in T cell function is not well understood.

Purpose of the Study:

  • To investigate the expression of AKAPs in T cells.
  • To determine the physiological significance of AKAP-PKA interactions in T cells.

Main Methods:

  • Analysis of AKAP expression in CD4(+) T cells.
  • Disruption of AKAP-PKA interactions.
  • Measurement of cytokine production (IL-2, IL-4, IL-5, IFN-gamma).
  • Assessment of T cell proliferation and response to cAMP-elevating agents.

Main Results:

  • CD4(+) T cells express eight AKAPs.
  • Disrupting AKAP-PKA interaction led to spontaneous high production of IL-2, IL-4, IL-5, and IFN-gamma.
  • AKAP-PKA disruption enhanced T cell proliferation synergistically with antigen stimulation.
  • Disrupted AKAP-PKA interaction made T cells insensitive to cAMP-elevating agents.

Conclusions:

  • AKAPs, via PKA, are critical for maintaining T cell homeostasis.
  • AKAPs regulate T cell sensitivity to cAMP-mediated signals.
  • Targeting AKAP-PKA interactions may offer therapeutic strategies for immune modulation.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...